ÂÒÂ×Ðã

ÂÒÂ×Ðã and our partner institutions have multiple strengths, providing a unique foundation for studies related to antimicrobial resistance.

Clinical integration

Close links with clinical facilities ensure that research is based on a sound understanding of clinical needs, and clinical platforms are available for testing new treatments, control strategies, and diagnostic or other tools.

ÂÒÂ×Ðã has strong links with ÂÒÂ×ÐãH and other major hospital sites, including the , and . The provides a key platform for clinical research and piloting of innovative practice, and has adopted antimicrobial resistance as one of its key themes.

Through - an academic health science partnership with over 40 higher education and NHS members - ÂÒÂ×Ðã has access to a community of 100,000 health professionals and academics, plus associated groups, who meet the health needs of some six million people.

ÂÒÂ×Ðã also has exceptional strengths in clinical trials, hosting a Comprehensive Clinical Trials Unit as well as the MRC Clinical Trials Unit, which is involved in several major antibiotic trials.

Academic partners

Through ÂÒÂ×ÐãPartners and other formal and informal partnerships, ÂÒÂ×Ðã is part of an extensive academic network of researchers working on microbial pathogens, infection and antimicrobial resistance.

Our researchers maintain multiple collaborations with colleagues at the , at , at the , and at many other leading centres of research - in the UK and internationally.

Cross-disciplinary connections

ÂÒÂ×Ðã has a strong commitment to cross-disciplinary research. Researchers in the School of Life and Medical Sciences frequently collaborate with colleagues working in other disciplines, including Engineering, Computer Science and Chemistry.

Nanotechnology is a particular strength, with innovative being carried out on nano-sensors with a variety of possible uses in diagnostics and antibiotic development.

Health informatics is a further strength, with cross-disciplinary networking facilitated by the ÂÒÂ×Ðã Institute of Digital Health. ÂÒÂ×Ðã is a key partner in the , a centre of excellence in research based on electronic health records. ÂÒÂ×Ðã researchers lead the Farr Institute @ London's infection workstream.

Industrial partners

ÂÒÂ×Ðã is committed to working in . We collaborate with many small biotech companies in the UK and internationally, and have a long history of productive relationships with large pharmaceutical companies.

Public outreach

ÂÒÂ×Ðã is highly supportive of staff working in public outreach. We have a dedicated public engagement unit and provide financial support for projects and training, for students and academics.

Steering group

Activities of the ÂÒÂ×Ðã Antimicrobial Resistance Network are overseen by a multidisciplinary steering group.

Join the ÂÒÂ×Ðã Antimicrobial Resistance Network

If you are a member of ÂÒÂ×Ðã or an institution affiliated to ÂÒÂ×ÐãPartners and would like to join the ÂÒÂ×Ðã Antimicrobial Resistance Network, contact Dr Lena Ciric, Network Coordinator.